VAERS Explorer
Back to explore

Report #2837334

Received Apr 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
MO
Recovered
Unknown
Vaccinated
Apr 21, 2025
Onset
Apr 21, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKX010526—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

Patient involved has not reported any medical concerns or symptoms/ No additional AE/PQC.; Expired dose of VARIVAX that was administered; This spontaneous report was received from a medical assistant, regarding a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent (BAXTER STERILE DILUENT) . On 21-Apr-2025, the patient was vaccinated with an expired dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) at a dose of 0.5 mL (Two dose series) as prophylaxis (lot number: X010526, which was determined to be valid, with an expiration date on 11-Apr-2025) (strength, scheme, route and anatomical location of administration were not reported) (Product use issue) The patient did not reported any medical concerns or symptoms/ No additional AE/PQC.

Other medications

VARIVAX